Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH
FRONTIERS IN PHARMACOLOGY, cilt.17, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17
- Basım Tarihi: 2026
- Doi Numarası: 10.3389/fphar.2026.1823203
- Dergi Adı: FRONTIERS IN PHARMACOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals, Natural Science Collection (ProQuest), Biological Science Database (ProQuest)
- Anahtar Kelimeler: DNL <italic>de novo</italic> lipogenesis, hepatic steatosis, JNK (c-Jun N-terminal kinase), MASLD, new drug
- Atatürk Üniversitesi Adresli: Evet